CorFlow Therapeutics

CorFlow Therapeutics is a company that develops diagnostic and therapeutic medical devices that are designed to enhance microvascular obstructions after a heart attack.

CorFlow's controlled flow infusion system measures the degree of microvascular obstruction using a proprietary microvascular resistance concept, it compares peri-procedural dMVR values to post-procedure contrast-enhanced Magnetic Resonance Imaging (MRI), allowing interventional cardiologists to diagnose and treat MVO in severe heart attack patients and reducing the short-term and long-term complication rates in patients.